Latest MicroRNA Stories
-RG-101 Achieves Sustained HCV Viral Suppression with Favorable Safety and Tolerability- LA JOLLA, Calif., April 25, 2015 /PRNewswire/ -- Regulus Therapeutics Inc.
DUBLIN, April 14, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/wflk64/global_mirna) has announced the addition of the "Global
-Regulus Earns $2.5 Million Milestone Payment from AstraZeneca- LA JOLLA, Calif., April 7, 2015 /PRNewswire/ --
Scientists have discovered a small RNA molecule known as miR-182 that can curb cancer-causing genes in mice with a deadly and incurable kind of brain tumor, glioblastoma mulitforme (GBM), according to a new study published in the journal Genes & Development.
Researchers at UC Davis have unraveled some of these relationships, identifying several interactions that directly impact liver and colon cancer. SACRAMENTO,
LA JOLLA, Calif., March 25, 2015 /PRNewswire/ -- Regulus Therapeutics Inc.
LONDON, March 23, 2015 /PRNewswire/ -- The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as well as commercial players.
DALLAS, March 19, 2015 /PRNewswire/ -- Cancer cell resistance to chemotherapy is a major cause of death in patients with colorectal cancer.
LA JOLLA, Calif., Feb. 19, 2015 /PRNewswire/ -- Regulus Therapeutics Inc.
- Achieved Key 2014 'Clinical Map Initiative' Goals to Advance microRNA Therapeutics Pipeline - LA JOLLA, Calif., Feb.
- A serpent whose bite was fabled to produce intense thirst.